Gad Soffer, Chief Operating Officer at Atara Biotherapeutics, Inc. (ATRA), sold 16,489 shares at $50.00 ($821K) on 2015-08-17, disclosed to the SEC on 2015-08-19.
Scheduled sale ($821k) by Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $50.00 | 8,778 | $439K | 53.5% |
| 2 | $49.26 | 4,284 | $211K | 25.7% |
| 3 | $49.78 | 3,427 | $171K | 20.8% |
| Total | $49.76 avg | 16,489 | $821K | 100% |
| Filing → |
| ATRA | SELL | 2017-08-17 | $141K | — | Filing → |
| ATRA | SELL | 2017-05-17 | $192K | — | Filing → |
| ATRA | SELL | 2017-03-13 | $50K | — | Filing → |